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Abstract 
The electroneutral exchange of chloride and bicarbonate across the human erythrocyte membrane is facilitated by Band 3, a 911 amino acid 
glycoprotein. The 43 kDa amino-terminal cytosolic domain binds the cytoskeleton, haemoglobin and glycolytic enzymes. The 52 kDa carboxyl- 
terminal membrane domain mediates anion transport. The protein is a functional dimer, in which the two subunits probably interact with one another 
by an allosteric mechanism. It is proposed that the link between the mobile cytoplasmic and the membrane-spanning domains of the protein is flexible, 
based on recent biochemical, biophysical and structural data. This explains the long-standing puzzle that attachment to the cytoskeletal spectrin and 
actin does not appear to restrict he rotational movement of the Band 3 protein in the erythrocyte membrane. In the Band 3 isoform from the Southeast 
Asian Ovalocytes (SAO) this link is altered, resulting a tighter attachment of the cytoskeleton to the plasma membrane and a more rigid red blood 
cell. 
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1. Introduction 
Few proteins have as many diverse important biologi- 
cal functions as the Band 3 protein from the erythrocyte 
membrane. It serves simultaneously as an anion trans- 
porter, an anchor for the cytoskeleton, haemoglobin and 
glycolytic enzymes, and as a senescence antigen. 
Band 3 plays a critical role in the COz transport sys- 
tem, where carbon dioxide is carried as bicarbonate in 
the blood plasma. Since the solubility of carbon dioxide 
in the blood is rather low, the CO2 molecule which dif- 
fuses into the erythrocyte through the plasma membrane 
is converted into HCO,- by cytosolic carbonic anhy- 
drase. The bicarbonate anion is then transported out of 
the cell by the Band 3 protein in exchange for a Cl- anion 
[I]. When the blood reaches the lung, the above exchange 
process is reversed as a result of a CO2 pressure gradient 
between the blood and the lung alveoli. In this way, more 
than two thirds of the CO2 molecules are transported in 
the form of HCO,-. Each Band 3 protein molecule trans- 
ports 10’ pairs of monovalent anions per second. This 
HCO,-/Cl- exchange is the largest ion-specific flux 
known for any single cell in the body [2]. 
Band 3, being the most abundant protein in the eryth- 
rocyte plasma membrane (1.2 x lo6 copies per cell, 
roughly 25% of the total membrane protein), also serves 
as a protein anchor, connecting soluble cytoplasmic 
proteins and components of the cytoskeleton to the 
membrane [3]. Spectrin binds to Band 3 via ankyrin and 
Band 4.1. These interactions with cytoskeletal proteins 
make Band 3 essential for maintaining cell shape and 
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mechanical strength [4]. It is also known that the protein 
provides binding sites for haemoglobin, hemichrome and 
some glycolytic enzymes [3]. 
It has become clear in the last decade that Band 3 also 
has a third function. The protein acts as a senescence 
antigen for aged and damaged red cells [5,6]. Clustering 
of Band 3 in the erythrocyte membrane triggers binding 
of antibodies to an extracellular part of the protein and 
causes the removal of aged or damaged red cells [7]. 
Proteolysis and gene sequencing have revealed that 
Band 3 has two structurally distinct domains [8.9]. The 
amino-terminal domain (residue l-360) has a molecular 
weight of 43 kDa and is cytosolic. The carboxyl-terminal 
domain (residue 361-91 l), with a molecular weight of 52 
kDa, spans the plasma membrane multiple times [lO,l 11. 
The cytosolic domain contains the binding sites for the 
cytoskeletal proteins and glycolytic enzymes, while the 
membrane domain mediates anion transport even after 
the removal of the cytoplasmic domain [12-141. The 
membrane domain also contains a single N-linked glyco- 
sylation site on its extracellular surface that is not re- 
quired for transport [15]. 
The mechanism by which Band 3 regulates cell rigidity 
is not well understood. In addition, the cytoskeleton 
bound to Band 3 is highly dynamic [3]. How can Band 
3 perform its functional role as an anion transporter 
without interference from the attached cytoskeletal pro- 
teins? Recent biochemical, biophysical and structural ex- 
periments are throwing light onto these questions. A low 
resolution (20 A) three-dimensional structure of the 
membrane domain of human Band 3 has recently been 
obtained [16]. In the present minireview, I will sum- 
marise the structural information, and correlate it with 
the experimental data obtained by other methods. 
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2. The membrane domain has a canyon-like structure 
Two reports on two-dimensional crystallization of 
Band 3 protein or its membrane domain appeared in 
1993 [17,18]. The three-dimensional structure of the 
membrane domain has been determined to 20 A resolu- 
tion by electron microscopy and image reconstruction 
[ 161. The dimeric domain shows a canyon-like structure, 
consisting of a basal domain and two large protrusions 
(Fig. 1). The basal domain is roughly 40 A thick. The two 
protrusions are 80 A long and 25 A wide, with a height 
of 40 A. They enclose a space of 55 A wide at the top, 
which narrows down to 25 A at the bottom on the sur- 
face of the basal domain. In addition, there is a depres- 
sion at the dimer interface on each side of the basal 
domain. 
The basal domain has been proposed to be the portion 
of the protein that spans the lipid bilayer [16]. The two 
protrusions are believed to represent he loops connect- 
ing the trans-membrane fragments in the cytosol and the 
two termini of the polypeptide. The cross-sectional area 
of the basal domain is consistent with the 1Chelix model 
of the protein [ 10, 1 1,191, although a 1Zhelix model can- 
not be ruled out, given the limited accuracy in estimating 
the cross-section from a low-resolution map. The N- 
linked oligosaccharide molecule that was pre-cleaved for 
crystallization is not visible in the map. Beppu et al. [20] 
have recently suggested that the antibody binding site is 
located on the oligosaccharide molecule, based on evi- 
dence from competitive inhibition of antibody binding to 
the red cells modified with SH-blocking agents. On the 
other hand, Lutz et al. [21] found that purified, naturally 
occurring anti-Band 3 antibody binds to polypeptide 
rather than carbohydrate within Band 3 protein. It re- 
mains to be seen which of these two possibilities is cor- 
rect. 
The dimer is believed to be the basic functional unit 
for anion transport [ 181. The depressions at the dimer 
interface on the two surface of the basal domain may 
represent the openings of the anion transport channel 
[16], as suggested in the dimeric cavity model of the 
protein molecule [22]. In the three-dimensional map, the 
negative stain partially penetrated into the channel from 
both side. In the middle of the membrane, the density is 
the highest, which probably represents the barrier to 
anion transport. This is consistent with the thin barrier 
model of anion transport [lo]. The protein shown in Fig. 
lc is probably in its inward-facing conformation, in 
which the anion binding site faces the cytoplasmic side 
and the barrier faces the exterior surface. The depression 
in the structure on the tentative cytosolic side of the 
membrane is indeed deeper than the one on the opposite 
side, as expected for the inward-facing conformation. 
The inner surface of the canyon may be positively 
charged and may participate in the anion selection, as 
originally suggested by Jay and Cantley [22]. It is inter- 
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esting to note that the same authors even predicted the 
experiment by which to verify their proposal on the mo- 
lecular structure of Band 3: ‘Information from two-di- 
mensional crystals would be extremely valuable in as- 
sessing the proposed dimeric cavity model’ [22]. 
3. %o subunits in the dimer interact allosterically 
The dimeric structure with a channel at the dimer 
interface suggests that allosteric subunit interactions 
may be involved in the anion transport cycle changing 
the conformational orientation of anion binding sites 
[ 16,181. Recent experimental evidence from kinetic stud- 
ies indeed supports the notion of allosteric interactions 
between the two subunits in the Band 3 dimer [23], as 
summarised below. 
Liu and Knauf [24] showed that binding of eosin-5- 
maleimide to one Band 3 monomer induced a conforma- 
tional change in the adjacent monomer in the dimer, by 
measuring the dependence of reaction rate to the inhibi- 
tor concentration. Similarly, covalent labelling of one 
Band 3 subunit with 4,4’-diisothiocyanodihydrostilbene- 
2,2’-disulfonate (H,DIDS) significantly altered reversi- 
ble binding of the inhibitor to the second subunit in the 
dimer [25]. In addition, dual-wavelength spectroscopic 
experiments howed that intersubunit allosteric hyster- 
esis made a significant contribution to dithionite trans- 
port by Band 3 [26]. 
Van Dort et al. [27] recently provided in situ structural 
evidence supporting the existence of ligand-mediated 
subunit interactions within the oligomeric transporter. 
They investigated the temperature shift of the calorimet- 
ric endotherm (the C-transition) of the membrane do- 
main of Band 3 upon binding by the inhibitor 4,4’-diiso- 
thiocyanostilbene-2,2’-disulfonate (DIDS). A distinctly 
non-linear correlation was found, implying that the ther- 
mal unfolding of the dimeric membrane domain was 
modulated by allosteric interactions between the sub- 
units. 
An allosteric oligomeric arrangement is not unique to 
Band 3. In fact, many transport proteins are oligomers 
[28,29]. An oligomeric channel not only offers the poten- 
tial of regulation by allosteric change, but also has the 
advantage of being more economical with respect o ge- 
netic information [ 181. 
4. The link between the cytoplasmic and the membrane 
domains is flexible 
The cytoskeleton binds to the plasma membrane via 
Band 3. The mobility of the Band 3 protein itself is, 
therefore, of importance to the mechanical rigidity of the 
cytoskeleton and of the whole cell [4]. It has been known 
for many years that the interaction between the cytosolic 
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Fig. 1. Structure of the membrane domain of the Band 3 protein determined by electron microscopy and image reconstruction of two-dimensional 
crystals. (a) Projection map derived from the hexagonal sheets. (b) Projection map from the tubular crystal form. (c) Three-dimensional map 
determined from the hexagonal sheets. The bulky basal domain is probably embedded in the lipid bilayer, indicated by the two semi-transparent planes. 
The protrusions above the basal domain are on the cytosolic side of the membrane, forming two sides of a canyon that leads to a depression which 
is probably the entrance to a pore. Comparing the projection maps and the three-dimensional map, it seems that the protrusions in the cytosol adapt 
two different conformations in the two crystal forms (from [16,18]). 
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and membrane domain of the protein is minimal [30]. 
Recent spectroscopic and structural data further suggest 
that the part of the polypeptide connecting the cytoplas- 
mic and the membrane domains of the Band 3 protein 
is flexible. In other words, there is a hinge between the 
two domains. 
Some spectroscopic evidence is reviewed first. Using 
polarised delayed luminescence of the intact and the pro- 
teolized Band 3, Matayoshi and Jovin [31] found that. 
beside of the two slow-rotating populations of Band 3, 
there was a highly mobile group of the protein in ghost 
and intact erythrocyte cells exhibiting a correlation time 
which is consistent with that expected for a free rota- 
tional diffusion of a Band 3 dimer. The mobility of this 
group was determined purely by viscous interactions 
within the lipid bilayer and was independent of the pres- 
ence or absence of the cytoplasmic domain. Using the 
technique of time-resolved phosphorescence anisotropy, 
McPherson et al. [32] have also observed that cross- 
linking of Band 3 via hemichromes caused substantial 
immobilisation of the membrane domain of Band 3. The 
motion of the cytoplasmic domain was only partially 
restricted, suggesting that the cytoplasmic and the mem- 
brane domains are independently mobile. 
Another line of evidence came from recent structural 
studies. The dimeric membrane domain of the Band 3 
protein was crystallised into two forms of two-dimen- 
sional crystals, hexagonal sheets, and helical tubes [18]. 
Comparing the projection maps and the three-dimen- 
sional map obtained from the hexagonal sheets, it is 
evident that the protrusion of the membrane domain in 
the cytosol adapts two different conformations in the 
two crystal forms [16,18]. The protrusion, or part of it, 
is rotated by about 60” between the two forms. There- 
fore, the connector (residues 361403) between the cyto- 
plasmic and the membrane domains of the Band 3 pro- 
spectrin 
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tein is most likely to be flexible (Fig. 2). The region 
around residue 360 is poorly conserved among other 
anion exchanger isomers. There is also a protease sensi- 
tive site in the region. 
The existence of a flexible hinge between the two do- 
mains helps to explain a long-standing puzzle. Cherry et 
al. [33] observed that the removal of spectrin and actin 
from the erythrocyte membrane resulted in little or no 
enhancement of Band 3 rotational mobility, a finding 
that has been verified since [4,34]. Therefore, these cy- 
toskeletal proteins do not restrict the rotation of Band 
3. Similarly, selective proteolysis of ankyrin, or incubat- 
ing the ghosts at 70°C at which temperature ankyrin was 
expected to be denatured, had no effect on Band 3 rota- 
tion [35]. It should be noted that Cherry et al. [33] meas- 
ured the rotational mobility of only the membrane do- 
main of Band 3, since the probe for mobility measure- 
ment, eosin-5-maleimide, binds to residue Lys-430 in this 
domain [36]. 
Two possible explanations have been suggested to ac- 
count for this surprising effect: (i) the flexibility of the 
cytoplasmic domain of the Band 3 protein to which the 
cytoskeleton is attached [32], and (ii) the flexibility of 
spectrin [37]. The second factor is probably not impor- 
tant. Although spectrin molecule is flexible in solution, 
the cytoskeletal network formed from spectrin and other 
molecules will certainly make a relatively tight angular 
restriction to the Band 3 protein. Here we propose that 
the lack of restrictions to the membrane domain of Band 
3 by the cytoskeleton is, at least in part, due to the 
presence of the flexible hinge between the cytoplasmic 
and the membrane domains of the protein. The restric- 
tion by the cytoskeleton only extends to the cytoplasmic 
domain, and the rotational diffusion of the membrane 
domain is not much affected. 
Why does the protein possess such a hinge? The cy- 
Fig. 2. Schematic picture showing the Band 3 protein and its interactions with the major cytoskeletal components. Spectrin binds to the cytoplasmic 
domain of Band 3 via a&y&. The zig-zag lines indicate the suggested flexible link between the cytoplasmic and the membrane domains of Band 3. 
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tosolic domain of Band 3 is highly elongated, with an 
axial ratio of 10, implying a molecule with a diameter of 
25 A and a length of more than 200 A [3]. This domain 
also has multiple conformations in situ upon binding to 
the cytoskeleton and to the various enzymes, so that is 
rather flexible [3,32]. The cytoskeleton also has a high 
flexibility [4]. In order to avoid undesired interference to 
anion transport from the cytoskeleton and from the cyto- 
plasmic domain, the Band 3 protein, not surprisingly, 
possesses a flexible portion that separates those mobile 
components from the anion transport channel of the 
protein [16]. 
If the hinge is so important for the function of the 
protein, what would happen when it is altered? Would 
the membrane skeleton become more rigid? Would the 
protein still transport anions? Nature has actually per- 
formed this experiment in the Band 3 isoform in the red 
cells of humans carrying Southeast Asian Ovalocytosis 
(SAO). 
5. SAO Band 3 
SAO is a red blood cell condition marked by altered 
cell morphology, which is found predominantly in indi- 
viduals of Southeast Asian decent. Ovalocytic red cells 
are found to be very rigid, and are resistant o invasion 
by various strains of malaria parasites in vitro [38,39]. 
People have been long searching for an explanation at 
the molecular level. 
The underlying molecular defect remained a mystery 
until Liu et al. [40] made the surprising observation that 
the ovalocytic phenotype was linked to a structural poly- 
morphism in Band 3, rather than to any change in the 
cytoskeletal components. It has been further established 
that a 9-amino-acid deletion near the N-terminal of the 
membrane domain (residues 400-408) is responsible for 
the unusual properties of the ovalocytic red cell [41-43]. 
This 9-amimo-acid deletion is around the cytoplasmic 
end of the first putative trans-membrane a-helix [l 11. 
How has the SAO Band 3 been changed by this? Detailed 
analysis on the mutant protein has been done in various 
laboratories [44-47]. The cytoplasmic domain of SAO 
Band 3 is structurally and functionally normal, as shown 
by (i) its calorimetric properties, (ii) native conforma- 
tional change at low pH, (iii) ability to form an inter- 
subunit disulphide bond, (iv) affinity and capacity for 
binding ankyrin and Band 4.1, and (v) kinetics of associ- 
ation with ankyrin [44]. The membrane domain of the 
SAO Band 3, on the other hand, is characterised by, (i) 
inability to transport anions [43,44], (ii) inability to bind 
stilbene disulfonates [44,47], (iii) different calorimetric 
properties [44], and (iv) different glycosylation pattern 
[47]. However, ligand-binding sites of a protein usually 
comprise only relatively small part of its structure. Often 
just a relatively small, localised structural change in the 
protein is sufficient o produce large change in its ligand 
binding, as has been shown for many proteins [48]. This 
seems also to be the case for the SAO Band 3 protein. 
There is strong evidence showing that the membrane 
domain of the SAO Band 3 does not undergo a gross 
structural change, namely, (i) both the accessibility to 
proteolytic enzymes and the proteolytic fragments are 
the same, (ii) CD spectra show no change [44], (iii) the 
protein inserts stably into the plasma membrane when 
expressed in oocytes [46], and (iv) the mutant protein 
forms homodimers and maybe even heterodimers with 
the native protein [47]. Taken together, the deletion of 
nine amino acids at this site near the cytoplasmic end of 
the membrane domain junction has a profound effect on 
anion transport and inhibitor binding apparently with- 
out dramatic change in the overall structure of the pro- 
tein. 
The translational and rotational diffusion of the SAO 
band 3 protein were greatly reduced [42,49]. 65% of the 
protein became immobile, compared with 35% in normal 
cells [45], resulting in a tighter attachment of the cy- 
toskeleton to the membrane and a highly rigid ovalocyte. 
Various mechanisms have been proposed to explain this 
unusual property. The inability to detect any gross struc- 
tural change in the two domains of the protein has 
prompted Moriyama et al. [44] and Schofield et al. [45] 
to suspect hat amino acids 400 to 408 form a flexible link 
between the membrane and cytosolic domain, and that 
this link has been deleted in the SAO isoform of the 
protein. With the newly available structural information 
(Fig. 1) [16,18], this suggestion seems to have gained 
ground. In Moriyama’s’ model [44], the deletion of the 
hinge is proposed to force the cytoplasmic domain to 
extend rigidly into the spectrin mesh. In this way, it is 
thought that much of the Band 3 not specifically associ- 
ated with cytoskeleton components became trapped 
among them and unable to diffuse laterally. This model, 
however, cannot explain the reduced rotational diffusion 
of Band 3. By comparison, in the model proposed by 
Schofield et al., [45], the adaptation of bound Band 3 to 
the displacement of cytoskeleton is proposed to take the 
form of a flexural motion near the membrane surface in 
the normal red cell. In the Ovalocytic Band 3 it is this 
hinge that has been deleted. In such a way, the cytoplas- 
mic domain cannot be bent easily, resulting in a stronger 
resistant shearing-force to any movement of the cy- 
toskeleton. 
A slight modification can be made to the above mod- 
els. The amino acids 400 to 408 are highly conserved in 
the Band 3 protein [9]. The first membrane spanning 
a-helix probably starts at Pro-403 [l 1,191. Therefore, res- 
idues 403 to 408 may not actually account for the entire 
hinge, although the exact position of the flexible frag- 
ment is unknown in the sequence (361402). Their dele- 
tion probably does not eliminate the flexible peptide but 
rather have changed its conformation to make it become 
D.N. WanglFEBS Letters 346 (1994) 26-31 
more rigid. As a result, the cytoplasmic domain may 
become more firmly attached to the membrane domain 
therefore also to the plasma membrane. 
Since it is found that SAO Band 3 contains a higher 
proportion of tetramers [47] and the protein even forms 
long strings of polymers in vivo [50], the change in the 
oligomeric state probably also plays a role. It would not 
be surprising find that several mechanisms operate si- 
multaneously in vivo. 
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